- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01049607
Stapler Hepatectomy for Elective Liver Resection (CRUNSH)
May 16, 2013 updated by: Nuh Rahbari
Clamp-Crushing vs. Stapler Hepatectomy for Transection of the Parenchyma in Elective Hepatic Resection: CRUNSH - A Randomized Controlled Trial
There is clinical uncertainty and ongoing discussion among liver surgeons regarding the optimal method of parenchymal transection in patients undergoing elective hepatic resection.
While the clamp-crushing technique still represents the reference technique for routine liver resections, transection of liver parenchyma using vascular staplers may offer a new and safe technique potentially reducing intraoperative blood loss, operation time as well as peri-operative morbidity.
As morbidity of patients undergoing hepatic resection remains high, approaches to lower peri-operative complications are urgently required.
Due to the lack of evidence it has to be evaluated, if the technique of stapler hepatectomy decreases intraoperative blood loss as a highly relevant predictor of peri-operative complications, patients' hospital stay and finally health care expenditures.
These advantages would favor stapler hepatectomy to be applied in routine liver resections.
As RCTs are generally considered to generate the most valid scientific evidence on a treatment's effects, the present trial evaluates potential benefits of stapler hepatectomy in a randomized fashion.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
130
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
BW
-
Heidelberg, BW, Germany, 69120
- Department of General, Visceral and Transplantation Surgery, University of Heidelberg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients scheduled for elective hepatic resection
- Stapler hepatectomy and clamp-crushing feasible based on preoperative imaging
- Age equal or greater than 18 years
- Informed consent
Exclusion Criteria:
- Participation in concurrent intervention trials
- Expected lack of compliance
- Impaired mental state or language problems
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Clamp-Crush technique
|
The transectional line is marked and the liver capsule is cauterized.
The liver parenchyma is then crushed stepwise using a regular Pèan clamp.
Vessels and bile ducts are ligated or clipped.
Vessels of less than 2mm diameter are coagulated with the irrigated bipolar forceps.
|
|
Experimental: Stapler hepatectomy
|
The transectional line is marked and the liver capsule is cauterized.
For subsequent transection of the hepatic parenchyma, the liver tissue is fractured with a vascular clamp in a stepwise fashion and subsequently divided with endo GIA vascular staplers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Intraoperative blood loss
Time Frame: 2.5 hours
|
2.5 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jürgen Weitz, MD, MSc, Department of General, Visceral and Transplantation Surgery, University of Heidelberg
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Rahbari NN, Elbers H, Koch M, Vogler P, Striebel F, Bruckner T, Mehrabi A, Schemmer P, Buchler MW, Weitz J. Randomized clinical trial of stapler versus clamp-crushing transection in elective liver resection. Br J Surg. 2014 Feb;101(3):200-7. doi: 10.1002/bjs.9387. Epub 2014 Jan 8.
- Rahbari NN, Elbers H, Koch M, Bruckner T, Vogler P, Striebel F, Schemmer P, Mehrabi A, Buchler MW, Weitz J. Clamp-crushing versus stapler hepatectomy for transection of the parenchyma in elective hepatic resection (CRUNSH)--a randomized controlled trial (NCT01049607). BMC Surg. 2011 Sep 4;11:22. doi: 10.1186/1471-2482-11-22.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
October 1, 2011
Study Completion (Actual)
March 1, 2012
Study Registration Dates
First Submitted
January 13, 2010
First Submitted That Met QC Criteria
January 13, 2010
First Posted (Estimate)
January 14, 2010
Study Record Updates
Last Update Posted (Estimate)
May 17, 2013
Last Update Submitted That Met QC Criteria
May 16, 2013
Last Verified
May 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- NNR-03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hepatic Resection
-
Polyganics BVGenaeCompletedPancreatectomy | Hepatic ResectionGermany
-
University Medical Center GroningenCompletedElective Hepatic ResectionNetherlands
-
Kasr El Aini HospitalRecruitingAnalgesia | Hepatic Resection SurgeryEgypt
-
Assistance Publique - Hôpitaux de ParisTerminatedLaparotomy | Hepatic ResectionFrance
-
Baxter Healthcare CorporationBaxter Innovations GmbHCompleted
-
University Hospital Inselspital, BerneTerminatedLiver Failure | Liver ResectionSwitzerland
-
National Taiwan University HospitalCompleted
-
University of MilanCompletedHepatectomy | Bile Leak | Hepatic Resection | Biliary Fistula | Liver ResectionItaly
-
Fudan UniversityUnknownPredictive Value of ICG Clearance Measurement During Selective Hepatic Vascular Trial Clamping on Remnant Liver Function After Anatomic Liver ResectionChina
-
University of California, San DiegoRecruitingAnesthesia, Local | Acute Pain | Anesthesia | Hepatic ResectionUnited States
Clinical Trials on Clamp-Crush technique
-
Mansoura UniversityCompletedHepatic TransplantationEgypt
-
Yonsei UniversityRecruitingCoronary Artery DiseaseKorea, Republic of
-
Shao PengfeiRecruitingRenal Cancer | Renal and Urinary Disorders | Renal ParticialChina
-
Johns Hopkins UniversityBill and Melinda Gates FoundationCompleted
-
Aswan UniversityCompletedMask Ventilation | Obesity & Overweight | Obese Patients (BMI ≥ 30 kg/m²) | Bag-mask VentilationEgypt
-
Fundación EPICWithdrawn
-
University of AarhusCompletedComparison Between Hypoglycemic Counter Regulatory Responses in Type 1 Diabetics vs Control SubjectsHypoglycemia | Diabetes Mellitus, Type 1Denmark
-
The Second Hospital of Anhui Medical UniversityThe First Affiliated Hospital of Anhui Medical UniversityCompletedHepatobiliary DiseaseChina
-
Assistance Publique - Hôpitaux de ParisTerminatedLiver Cirrhosis | Carcinoma, Hepatocellular | Liver NeoplasmsFrance
-
Tommaso GoriCompleted